Senior Director, Clinical Data Systems & Clinical Programming
Solid Biosciences
Summary
Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases. We are seeking a Senior Director, Clinical Data Systems & Clinical Programming to provide strategic leadership and operational oversight for clinical technology platforms, clinical database programming, data integrations, and associated vendor partnerships across the clinical development portfolio.
Job description
Key Position Responsibilities
- Develop and execute the clinical systems and clinical programming roadmap, including governance, standards, lifecycle management, system ownership, decision rights, controls, documentation expectations, and escalation pathways across EDC, IRT, eCOA/ePRO, clinical data repositories, and related platforms.
- Provide strategic and operational oversight for EDC database design, configuration, programming, validation, release, maintenance, and archival, including standards for electronic case report forms, edit checks, derivations, database specifications, testing, and documentation.
- Provide leadership and governance for randomization, trial supply management, eCOA/ePRO, and other patient- or site-facing clinical technologies, ensuring protocol requirements are accurately translated into specifications, test plans, procedures, and validated configurations.
- Partner with Clinical Supply and Clinical Operations to align enrollment assumptions, randomization requirements, dispensing logic, and supply forecasts, and ensure reliable integrations and reconciliations across clinical technology platforms and external data providers.
- Lead the design and evolution of scalable clinical data flows, repositories, integration patterns, and data lineage capabilities in partnership with IT, Data Management, Biostatistics, and Statistical Programming.
- Oversee secure and reliable data transfers, interfaces, APIs, and ingestion workflows, establishing standards for metadata, traceability, data quality monitoring, issue management, and technical documentation to enable timely access to integrated clinical data.
- Lead the evaluation, selection, contracting, governance, financial oversight, and performance management of clinical technology vendors and service providers, including scopes of work, budgets, timelines, deliverables, risks, change orders, and continuity planning.
- Ensure clinical systems and supporting processes comply with GCP, 21 CFR Part 11, data integrity principles, company procedures, and applicable global regulations, with complete, traceable, current, and inspection-ready validation documentation.
- Partner with Quality and IT on risk assessments, audits, deviations, corrective and preventive actions, access controls, business continuity, system retirement, inspection readiness, and health authority interactions involving clinical systems, databases, and data flows.
- Serve as the senior subject matter expert for clinical systems and clinical database programming, providing strategic input during protocol development, study planning, vendor selection, and operational readiness and communicating key decisions, risks, dependencies, and performance to leadership and study teams.
- Build and develop a high-performing clinical systems and clinical programming organization, defining roles, resource plans, operating models, objectives, and development opportunities while balancing internal capabilities with external partnerships and flexible resourcing models.
Experience Requirements
- Bachelor's degree in life sciences, computer science, information systems, biostatistics, engineering, or a related field required; advanced degree or an equivalent combination of education and relevant industry experience preferred.
- 15 or more years of progressive experience in clinical systems, clinical data management, database programming, biometrics operations, or related clinical development functions within biotechnology, pharmaceutical, or CRO environments.
- Demonstrated leadership experience managing people, vendors, complex programs, budgets, and cross-functional initiatives, including establishment of functional strategy, governance, standards, and scalable operating processes.
- Extensive experience supporting Phase 1 through Phase 3 clinical trials and global development programs, with significant expertise in EDC database development, IRT, eCOA/ePRO, computerized systems validation, data integrations, external data, clinical data flows, and database lock processes.
- Deep working knowledge of EDC platforms such as Medidata Rave, Veeva CDMS, Oracle InForm, or comparable systems, as well as clinical data standards, metadata, data lineage, repositories, APIs, cloud-based platforms, and data quality monitoring.
- Strong knowledge of GCP, 21 CFR Part 11, computerized systems validation, data integrity, and applicable global regulatory expectations, with experience supporting audits, regulatory inspections, and inspection readiness activities.
- Strategic judgment and the ability to translate portfolio needs into pragmatic technology and operating plans, bridge clinical, operational, technical, quality, and regulatory perspectives, and manage multiple priorities in a dynamic, resource-conscious biotechnology environment.
- Excellent vendor management, negotiation, communication, and stakeholder leadership skills; familiarity with SQL, SAS, R, Python, or other relevant programming technologies and experience in rare disease, gene therapy, biologics, or specialty biotechnology are preferred.
Requirements
- Bachelor's degree in life sciences, computer science, information systems, biostatistics, engineering, or a related field
- 15 or more years of progressive experience in clinical systems, clinical data management, database programming, biometrics operations, or related clinical development functions
- Demonstrated leadership experience managing people, vendors, complex programs, budgets, and cross-functional initiatives
- Extensive experience supporting Phase 1 through Phase 3 clinical trials and global development programs
- Expertise in EDC database development, IRT, eCOA/ePRO, computerized systems validation, data integrations, external data, clinical data flows, and database lock processes
- Deep working knowledge of EDC platforms such as Medidata Rave, Veeva CDMS, Oracle InForm, or comparable systems
- Knowledge of clinical data standards, metadata, data lineage, repositories, APIs, cloud-based platforms, and data quality monitoring
- Strong knowledge of GCP, 21 CFR Part 11, computerized systems validation, data integrity, and applicable global regulatory expectations
- Experience supporting audits, regulatory inspections, and inspection readiness activities
- Strategic judgment and ability to translate portfolio needs into pragmatic technology and operating plans
- Excellent vendor management, negotiation, communication, and stakeholder leadership skills
- Familiarity with SQL, SAS, R, Python, or other relevant programming technologies (preferred)
- Experience in rare disease, gene therapy, biologics, or specialty biotechnology (preferred)
- Advanced degree or equivalent combination of education and relevant industry experience (preferred)
Benefits
- Health & Dental Insurance
- FSA & HSA
- 401(k) Matching
- Employee Stock Purchase Plan
- Mobile Phone Subsidy
- Tuition Reimbursement
- Vision Coverage
- Life Insurance
- Pet Insurance
- Employee Discount Program
- Employee Assistance Programs
- Subsidized Lunch
- Onsite Gym
- Employee Parking
- 12 Observed Holidays
- Winter Shutdown
- 15-day PTO
- 80-hour PTO Rollover
- 40-hour Sick Policy
- 8-hour Floating Holiday
Company overview
Solid Biosciences is a precision genetic medicine company focused on developing innovative gene therapies for rare neuromuscular and cardiac diseases. Founded in 2013 and headquartered in Charlestown, Massachusetts, the company has established itself as a leader in the biotechnology research sector with approximately 148 employees. Solid Biosciences' pipeline includes several promising gene therapy candidates targeting devastating conditions such as Duchenne muscular dystrophy (SGT-003), Friedreich's ataxia (SGT-212), catecholaminergic polymorphic ventricular tachycardia (SGT-501), and TNNT2-mediated dilated cardiomyopathy (SGT-601). The company employs a patient-focused approach, having been founded by individuals directly impacted by Duchenne muscular dystrophy, which drives their mission to improve the daily lives of patients living with rare genetic diseases. Beyond therapeutic development, Solid Biosciences is advancing innovative libraries of genetic regulators and enabling technologies designed to significantly impact gene therapy delivery across the industry. The company has raised substantial funding, including a recent $240 million private placement, and trades publicly on the NASDAQ under the symbol SLDB. Their research focuses on uniting experts in science, technology, disease management, and care to develop transformative precision genetic medicines.